Literature DB >> 34687901

Compartmentalized cAMP signaling in cardiac ventricular myocytes.

Shailesh R Agarwal1, Rinzhin T Sherpa1, Karni S Moshal1, Robert D Harvey2.   

Abstract

Activation of different receptors that act by generating the common second messenger cyclic adenosine monophosphate (cAMP) can elicit distinct functional responses in cardiac myocytes. Selectively sequestering cAMP activity to discrete intracellular microdomains is considered essential for generating receptor-specific responses. The processes that control this aspect of compartmentalized cAMP signaling, however, are not completely clear. Over the years, technological innovations have provided critical breakthroughs in advancing our understanding of the mechanisms underlying cAMP compartmentation. Some of the factors identified include localized production of cAMP by differential distribution of receptors, localized breakdown of this second messenger by targeted distribution of phosphodiesterase enzymes, and limited diffusion of cAMP by protein kinase A (PKA)-dependent buffering or physically restricted barriers. The aim of this review is to provide a discussion of our current knowledge and highlight some of the gaps that still exist in the field of cAMP compartmentation in cardiac myocytes.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Buffering; Cardiac myocytes; Phosphodiesterase; Prostaglandin receptor; Protein kinase A; Restricted spaces; beta-Adrenergic receptor; cAMP compartmentation

Mesh:

Substances:

Year:  2021        PMID: 34687901      PMCID: PMC8602782          DOI: 10.1016/j.cellsig.2021.110172

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  136 in total

1.  G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes.

Authors:  Brian P Head; Hemal H Patel; David M Roth; N Chin Lai; Ingrid R Niesman; Marilyn G Farquhar; Paul A Insel
Journal:  J Biol Chem       Date:  2005-06-16       Impact factor: 5.157

2.  Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart.

Authors:  Sanja Beca; Faiyaz Ahmad; Weixing Shen; Jie Liu; Samy Makary; Nazari Polidovitch; Junhui Sun; Steven Hockman; Youn Wook Chung; Matthew Movsesian; Elizabeth Murphy; Vincent Manganiello; Peter H Backx
Journal:  Circ Res       Date:  2012-11-19       Impact factor: 17.367

3.  Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.

Authors:  Michael A Crackower; Gavin Y Oudit; Ivona Kozieradzki; Renu Sarao; Hui Sun; Takehiko Sasaki; Emilio Hirsch; Akira Suzuki; Tetsuo Shioi; Junko Irie-Sasaki; Rajan Sah; Hai-Ying M Cheng; Vitalyi O Rybin; Giuseppe Lembo; Luigi Fratta; Antonio J Oliveira-dos-Santos; Jeffery L Benovic; C Ronald Kahn; Seigo Izumo; Susan F Steinberg; Matthias P Wymann; Peter H Backx; Josef M Penninger
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

Review 4.  cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.

Authors:  Miles D Houslay; George S Baillie; Donald H Maurice
Journal:  Circ Res       Date:  2007-04-13       Impact factor: 17.367

5.  Functional beta3-adrenoceptor in the human heart.

Authors:  C Gauthier; G Tavernier; F Charpentier; D Langin; H Le Marec
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes.

Authors:  Rennolds S Ostrom; Richard A Bundey; Paul A Insel
Journal:  J Biol Chem       Date:  2004-03-08       Impact factor: 5.157

Review 7.  Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system.

Authors:  Donald H Maurice; Daniel Palmer; Douglas G Tilley; Heather A Dunkerley; Stuart J Netherton; Daniel R Raymond; Hisham S Elbatarny; Sandra L Jimmo
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

8.  Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins.

Authors:  Stephen J Perry; George S Baillie; Trudy A Kohout; Ian McPhee; Maria M Magiera; Kok Long Ang; William E Miller; Alison J McLean; Marco Conti; Miles D Houslay; Robert J Lefkowitz
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

9.  A genetically encoded, fluorescent indicator for cyclic AMP in living cells.

Authors:  M Zaccolo; F De Giorgi; C Y Cho; L Feng; T Knapp; P A Negulescu; S S Taylor; R Y Tsien; T Pozzan
Journal:  Nat Cell Biol       Date:  2000-01       Impact factor: 28.824

10.  Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes.

Authors:  Manuela Zaccolo; Tullio Pozzan
Journal:  Science       Date:  2002-03-01       Impact factor: 47.728

View more
  1 in total

1.  Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes.

Authors:  Sergi Casabella-Ramón; Verónica Jiménez-Sábado; Carmen Tarifa; Sandra Casellas; Tien Tina Lu; Paloma Izquierdo-Castro; Ignasi Gich; Marcel Jiménez; Antonino Ginel; José M Guerra; S R Wayne Chen; Raul Benítez; Leif Hove-Madsen
Journal:  Biomedicines       Date:  2022-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.